These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 4967922)

  • 1. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of the resistance of mycobacteria].
    Savov N
    Vet Med Nauki; 1973; 10(2):39-49. PubMed ID: 4213759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dehydroabietylguanidine (DAG), a semisynthetic broad spectrum antibiotic with a special effect on mycobacteria].
    Muftie M
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):305-10. PubMed ID: 4977376
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of emetine hydrochloride on the growth of different mycobacteria strains].
    Schwartz E
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):115-25. PubMed ID: 4989350
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria].
    Robert J; Veziris N;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibiotic resistance of Mycobacterium. Standard test method and its clinical use in Japan].
    Ushiba D
    Torax; 1966 Mar; 15(1):14-24. PubMed ID: 4957544
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.
    West NP; Cergol KM; Xue M; Randall EJ; Britton WJ; Payne RJ
    Chem Commun (Camb); 2011 May; 47(18):5166-8. PubMed ID: 21384024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitubercular agents. 45. Antimycobacterial thiohydrazide].
    Waisser K; Odlerová Z; Houngbedji N; Thiel W; Mayer R
    Zentralbl Mikrobiol; 1989; 144(5):355-7. PubMed ID: 2515678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 18. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 19. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.